Developer of electrophysiology and structural heart devices designed to treat patients suffering from complex chronic cardiac, stroke and arrhythmia risk diseases. The company's devices are built around custom left atrial appendage occluder implants that provide synergistic modules like cardiac monitoring, ablation, or both modules, enabling medical professionals to offer cost-benefit treatments without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.
Developer of a medical device designed to help physicians treat atrial fibrillation. The company develops a medical device that selectively targets the origin of the problem from outside rather than inside the heart and uses a catheter to deliver short pulses of electrical energy into the clusters of neuronal cells, enabling patients to avail of the treatment without damaging the heart muscle.
Developer of non-invasive neurostimulation products designed to treat global health epidemics. The company's medical device technology offers transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus to allow for alterations in autonomic function, circadian regulation, and neuro-metabolic influence, enabling healthcare providers to provide drug-free options and improve patients' health outcomes.
Developer of connected intravascular medical device designed to help facilitate the treatment of cardiac arrhythmia. The company utilizes artificial intelligence (AI) and real-time tissue analysis through advanced four-dimensional imaging and improves structural heart interventions, enabling doctors to perform cardiac treatments that improve outcomes for patients, increase procedural safety, and reduce the cost to the healthcare system.